Use of GLP-1 Drugs for Obesity Linked to Lower Risk of Glaucoma

(MedPage Today) -- Use of GLP-1 receptor agonists for obesity was associated with a reduced risk of primary open-angle glaucoma (POAG) and ocular hypertension compared with other weight-loss medications, a retrospective cohort study suggested...